ReviewCurrent urology reports2012
Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria.
Review in Current urology reports, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Semiautomated pelvic lymph node treatment response evaluation for patients with advanced prostate cancer: based on MET-RADS-P guidelines.Cancer imaging : the official publication of the International Cancer Imaging Society · 2023Article
- The tumor volume after radical prostatectomy and its clinical impact on the prognosis of patients with localized prostate cancer.Scientific reports · 2022Article
- Which technology to select for primary focal treatment of prostate cancer?-European Section of Urotechnology (ESUT) position statement.Prostate cancer and prostatic diseases · 2018Review
- Cryosurgery, an alternative treatment option for organ-confined prostate cancer: current beliefs and practice patterns of urologists.International urology and nephrology · 2017Article
- Current status of cryotherapy for prostate and kidney cancer.Korean journal of urology · 2014Review
- Mechanisms of cryoablation: clinical consequences on malignant tumors.Cryobiology · 2014Review
- Prediction of prostate cancer to urethra distance by a pretreatment nomogram: urethral thermoprotection implication in cryoablation.Prostate cancer and prostatic diseases · 2013Article
- Refining treatment for the men who need it: lessons from the PIVOT trial.Translational andrology and urology · 2013Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Focal therapy for prostate cancer has been increasingly utilized with the goal of effective disease control while maximizing patient functional outcomes. The optimal patient selection criteria are not known and therefore are not standardized. This review compares the available expert panel consensus guidelines with the selection criteria utilized in recently published focal therapy trials. Because the data from focal trials are still maturing, the currently enrolling clinical trials are reviewed as well. In addition, the recent literature regarding technological advances in prostate biopsy and imaging strategies are added to the current guidelines to recommend a rationale for patient selection.
Indexed as
Identifiers
22298223What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.